FDA Seeks Speedier Seizure, Injunction Decisions Via Protocol Changes
This article was originally published in The Rose Sheet
Executive SummaryFDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.
You may also be interested in...
The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.